Welcome to our dedicated page for Beyond SEC filings (Ticker: BYON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Beyond, Inc. (NYSE: BYON) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. In its filings, the company is identified under the Bed Bath & Beyond, Inc. name, with Beyond, Inc. noted as the former name or former address where applicable. These documents offer detailed information on the company’s financial condition, governance, compensation arrangements, and certain transactions.
Current reports on Form 8-K feature prominently in Beyond, Inc.’s filing history. Recent 8-K filings describe events such as the appointment of the Executive Chairman and principal executive officer as Chief Executive Officer, the termination of the Chief Operating Officer’s employment and related transition arrangements, and the adoption of the Bed Bath & Beyond, Inc. 2025 Employment Inducement Equity Incentive Plan. Other 8-Ks report on financial results for specific quarters, including the release of earnings for the three and nine months ended September 30, 2025.
Beyond, Inc. also uses Form 8-K to disclose investment and financing activities. Filings detail the company’s participation in loans issued by The Container Store, Inc. under a term loan credit agreement, including purchase prices for participation interests and the resulting rights to interest payments, repayment of principal, and related remedies. These disclosures help investors understand how the company allocates capital outside its core retail operations.
In addition to current reports, investors can consult Beyond, Inc.’s annual reports on Form 10-K and quarterly reports on Form 10-Q (not reproduced in full here) for comprehensive financial statements, segment information, risk factors, and management’s discussion and analysis. Proxy statements referenced in 8-K filings provide further detail on executive compensation and governance matters.
On this page, AI-powered tools can assist users by summarizing lengthy filings, highlighting key items such as leadership changes, equity incentive plans, and significant loan participations, and helping locate information on quarterly and annual results, governance decisions, and other material events relevant to BYON shareholders.
Bed Bath & Beyond, Inc. filed an amended report to detail the employment agreement for Marcus Lemonis, who became Chief Executive Officer effective January 1, 2026. The agreement sets an annual base salary of $300,000 and makes him eligible for an annual cash bonus with a $2,200,000 target, based on performance goals set by the Board or its Compensation Committee.
In addition, the agreement contemplates equity awards of 1,500,000 restricted stock units that vest in four equal annual installments following the effective date and 600,000 performance shares (at target) eligible to vest over four one-year performance periods. These equity awards are expected to be granted under the company’s 2005 Equity Incentive Plan or a successor plan and are expected to be contingent on stockholder approval of plan amendments or a successor plan at the 2026 annual meeting. The agreement also includes severance provisions for certain qualifying terminations and customary non-competition and non-solicitation covenants.
Bed Bath & Beyond, Inc. reported that on January 9, 2026 it purchased an additional participation in term loans issued by The Container Store, Inc. under an existing Term Loan Credit Agreement. The aggregate purchase price for this new participation was $2,168,266.96, following an earlier purchase on November 25, 2025 for $6,461,843.09. Through these transactions, the company will share in the rights to receive interest and principal repayments on the loans, as well as any related enforcement or remedy rights under the credit agreement.
Bed Bath & Beyond, Inc. is registering shares to acquire The Brand House Collective (TBHC) in an all‑stock merger. TBHC will merge into a Bed Bath & Beyond subsidiary and become a wholly owned subsidiary of Bed Bath & Beyond.
Each share of TBHC common stock will be converted into 0.1993 shares of Bed Bath & Beyond common stock, plus cash instead of fractional shares. Using Bed Bath & Beyond’s November 21, 2025 NYSE closing price of $5.56, this implied about $1.11 of value per TBHC share at signing, though the actual value will move with Bed Bath & Beyond’s share price.
TBHC’s board unanimously recommends shareholders vote for the merger, an advisory vote on merger‑related executive compensation, and a possible adjournment to solicit more proxies. If completed, former TBHC holders are expected to own about 4.2% of the combined company, which will continue to trade on the NYSE under “BBBY,” while TBHC will be delisted from Nasdaq. If the deal fails under specified circumstances, TBHC may owe Bed Bath & Beyond a $1.0 million termination fee and a $0.3 million expense reimbursement.
Bed Bath & Beyond, Inc. reported a leadership change at the top of the company. The Board appointed Marcus Lemonis, currently Executive Chairman and the company’s principal executive officer, as Chief Executive Officer, effective January 1, 2026. He will continue to serve as Executive Chairman and principal executive officer, consolidating the company’s senior leadership roles under one individual. The company plans to enter into an employment agreement with Mr. Lemonis, with key terms to be disclosed in a later filing.
The company also ended the employment of Alexander Thomas, its Chief Operating Officer and principal operating officer, as of the same effective date. Mr. Thomas is expected to act as an advisor for a transition period after January 1, 2026 to support an orderly handover of his responsibilities.
Bed Bath & Beyond, Inc. reported that on November 25, 2025 it purchased, via a participation agreement, a portion of loans issued by The Container Store, Inc. under a term loan credit agreement originally dated January 28, 2025 and amended on September 15, 2025. The aggregate purchase price for the company’s participation in these loans was $6,461,843.09.
Through this participation, Bed Bath & Beyond will share in the right to receive interest and principal payments on the loans, as well as in any exercise of rights or remedies related to those loans.
Bed Bath & Beyond (BBBY) reported an equity award to a senior executive. On 11/14/2025, an officer serving as Executive Vice President, Chief Digital, Product, and Technology Officer received 116,686 restricted stock units (RSUs) of Bed Bath & Beyond common stock at a price of $0 per unit.
Each RSU represents a contingent right to receive one share of common stock. The award vests in three equal installments at the close of business on November 3, 2026, November 3, 2027 and November 3, 2028, with vested shares to be delivered to the executive promptly after each vesting date. Following this grant, the executive holds 116,686 derivative securities directly.
Bed Bath & Beyond, Inc. (BBBY) reported that one of its executives, serving as Executive Vice President, Chief Digital, Product, and Technology Officer, filed an initial ownership report on Form 3 as of 11/14/2025. The filing states that this officer currently does not beneficially own any Bed Bath & Beyond securities, and both the non-derivative and derivative ownership tables show no reported holdings.
Bed Bath & Beyond (BBBY) Chief Accounting Officer, who files individually, reported equity award activity and a warrant distribution. On 11/15/2025, the officer acquired 1,186 shares of common stock at an exercise price of $0.0001 through the vesting and settlement of restricted stock units, and disposed of 289 shares at $6.03, typically reflecting shares withheld or sold to cover taxes. Following these transactions, the officer directly holds 3,077 shares of common stock.
In the derivative table, the officer shows 26,906 restricted stock units beneficially owned after the reported RSU conversion, each representing one share of common stock, vesting in two equal installments on November 15, 2025 and November 15, 2026. The officer also acquired 218 common stock warrants with a $15.50 exercise price from an October 7, 2025 pro-rata distribution to all common shareholders, which become exercisable once an S-3 registration statement for the warrant shares is declared effective and remain exercisable through October 7, 2026.
Bed Bath & Beyond Inc.'s Chief Operating Officer reported equity transactions reflecting routine compensation activity. On 11/15/2025, 1,186 shares of common stock were acquired upon the vesting and settlement of restricted stock units at an exercise price of $0.0001 per share, and 343 shares were disposed of at $6.03 per share, typically consistent with tax withholding. Following these transactions, the reporting person directly owned 8,793 common shares and indirectly held 66 shares through a 401(k) plan balance as of 11/17/2025.
In the derivative table, 1,186 restricted stock units converted into common stock, leaving 43,143 derivative securities reported as beneficially owned. The filing also lists 794 common stock warrants with an exercise price of $15.50 per share, originally issued on 10/07/2025 as a pro-rata distribution. These warrants will become exercisable once a Form S-3 registering the underlying shares is declared effective by the SEC and may be exercised through 10/07/2026.
Bed Bath & Beyond Inc. (BBBY): A series of the Amplify ETF Trust filed a Schedule 13G reporting beneficial ownership of 4,496,275 shares of BBBY common stock, representing 6.53% of the class as of 09/30/2025.
The filer reports sole voting power over 4,496,275 shares and sole dispositive power over 4,496,275 shares, with no shared voting or dispositive power. The filing identifies the filer as an investment company registered under section 8 of the Investment Company Act of 1940.
The filing notes the fund’s clients have the right to receive or direct the receipt of dividends or sale proceeds from the reported securities, and that no one other person’s interest exceeds 5%.